Cardiovascular Drug Reviews focuses on extensive reviews on the pharmacology, pharmacokinetics, toxicology and clinical trials of new or potential cardiovascular drugs. These peer-reviewed articles are written by industrial or academic scientists who participated in the development of a particular drug. The Editorial Board is composed of eminent and highly reputable scientists.